2024-11-18 06:43:20
Ascletis Announces IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19 Accepted by China NMPA
Corporate/ 2023-07-24
Ascletis Announces IND Filing of Oral 3C...

HANGZHOU,China and SHAOXING,China,Nov. 29,2022--Ascletis Pharma Inc. (HKEX: 1672,"Ascletis") announces today that the Investigatio...

DetectedX Introduces ImageDx to Transform Image-Based Education at RSNA
Health/ 2023-07-22
DetectedX Introduces ImageDx to Transfor...

Showcases Momentum with New Customers,New Subscriber Options and the Addition of Professor László Tabár to the Executiv...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release